Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial

Abstract Background Studies reporting the effects of metabolic surgery, lifestyle intervention, and intensive insulin therapy for the remission of type 2 diabetes (T2DM) has been increasing, with fruitful results better conducted and yielded. However, there are only a few studies on the remission of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xue Yang, Zhiwei He, Li Yuan, Wenbin Huang, Doudou Li, Pingping Xiang, Yu Chen, Guofang Chen, Chao Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-10-01
Colecção:	BMC Endocrine Disorders
Assuntos:	Canagliflozin Type 2 diabetes mellitus Remission Metformin Sodium-glucose cotransporter-2 inhibitor
Acesso em linha:	https://doi.org/10.1186/s12902-023-01461-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!